Kimberly-Clark, a leading consumer products company, has agreed to acquire Kenvue, the maker of Tylenol, for $40 billion. This strategic move comes amidst a controversial debate surrounding the safety of Tylenol during pregnancy. Despite unsubstantiated claims from President Trump and others that Tylenol use can lead to autism, Kimberly-Clark believes that Tylenol can weather the storm. The acquisition aims to strengthen Kimberly-Clark's portfolio and capitalize on the enduring popularity of the Tylenol brand. The deal highlights Kimberly-Clark's confidence in the long-term viability of Tylenol, even in the face of unfounded allegations. The company's decision to invest in the acquisition suggests that it believes the scientific evidence supporting the safety and efficacy of Tylenol will prevail over the unproven claims. The acquisition is expected to enhance Kimberly-Clark's position in the consumer health market and provide opportunities for synergies and growth. It remains to be seen how the ongoing debate over Tylenol's safety will unfold, but Kimberly-Clark's bet on the brand's resilience underscores its strategic outlook.
Nov 3, 2025 → Nov 10, 2025
A comprehensive review has found no convincing evidence that paracetamol (acetaminophen) use during pregnancy is linked to an increased risk of autism or ADHD in children. The review was expedited to provide reliable information to…
Read original at The Guardian →2 updates from 2 sources over 6 days.
A comprehensive review has found no convincing evidence that paracetamol (acetaminophen) use during pregnancy is linked to an increased risk of autism or ADHD in children. The review was expedited to provide reliable…
Read original at The Guardian →Kimberly-Clark, a leading consumer products company, has agreed to acquire Kenvue, the maker of Tylenol, for $40 billion. This strategic move comes amidst a controversial debate surrounding the safety of Tylenol during…
Read original at NYT →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
A comprehensive review has found no convincing evidence that paracetamol (acetaminophen) use during pregnancy is linked to an increased risk of autism or ADHD in children. The review was expedited to provide reliable information to…
View source →Kimberly-Clark, a leading consumer products company, has agreed to acquire Kenvue, the maker of Tylenol, for $40 billion. This strategic move comes amidst a controversial debate surrounding the safety of Tylenol during pregnancy. Despite…
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
Long-running fight over Trump-backed maps takes another turn as absentee voting is already under way in Missouri. This blog is now closed. Sign up for US Breaking News emails Xi…
This new task force is Trump's latest response to the debate over AI safety.
The Trump administration’s decision to revoke the visa of a Peruvian judge who sided with a Chinese company in a port dispute puts a new spotlight on the growing US-China rivalry…
As Bosnians vote in an election this weekend, the country is embracing the US president’s family and friends.
On Equity, we discussed the Trump administration's attempts to rebrand AI.
Donald Trump and Xi Jinping discuss Taiwan arms sales every time they get together but the American stance on the self-ruled island remains unchanged following the Chinese…
